You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. PLASMA & BIOTHERAPIES - 05-02-2015

    SIPPET Study: interim analysis confirms the original hypothesis

    The Study on inhibitors in Hemophilia A is safe to continue after Investigators’ Meeting in San Francisco (Dec 2014)

    read more 
  2. PLASMA & BIOTHERAPIES - 16-10-2014

    Investigating inhibitor development in patients with Hemophilia A

    Lecture on state-of-the-art of the SIPPET Study presented by P.M. Mannucci, sponsored by Grifols, Kedrion and LFB

    read more 
  3. PLASMA & BIOTHERAPIES - 24-06-2014

    Counterfeit RhoGAM Ultra-Filtered PLUS used for preventing HDN found in India

    Johnson & Johnson Limited has identified counterfeit RhoGAM Ultra-Filtered PLUS in the state of West Bengal and Uttar Pradesh in India. This issue does not involve any other product manufactured or distributed by Ortho Clinical Diagnostics or Kedrion Biopharma India Pvt. Ltd.

    read more 
  4. PLASMA & BIOTHERAPIES - 14-04-2014

    Kedrion collection centers first to be certified in Hungary

    Plazmaferezis Állomás Kft achieves international PPTA certification

    read more 

Pages

For more information please contact: pressoffice@kedrion.com